ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $889,848,000 | +13.0% | 19,206,726 | -40.5% | 0.10% | +10.6% |
| Q1 2019 | $787,653,000 | +74.4% | 32,307,354 | +1.9% | 0.09% | +51.6% |
| Q4 2018 | $451,632,000 | +9.6% | 31,693,502 | +16.9% | 0.06% | +34.8% |
| Q3 2018 | $411,945,000 | +0.7% | 27,101,636 | +11.1% | 0.05% | -2.1% |
| Q2 2018 | $409,271,000 | +6.2% | 24,390,396 | +3.3% | 0.05% | +2.2% |
| Q1 2018 | $385,200,000 | +35.7% | 23,602,936 | +6.4% | 0.05% | +39.4% |
| Q4 2017 | $283,929,000 | +3.8% | 22,181,936 | -0.3% | 0.03% | 0.0% |
| Q3 2017 | $273,522,000 | +76.3% | 22,237,536 | +20.0% | 0.03% | +73.7% |
| Q2 2017 | $155,116,000 | -25.5% | 18,532,336 | -20.4% | 0.02% | -26.9% |
| Q1 2017 | $208,086,000 | -4.5% | 23,275,836 | -6.1% | 0.03% | -10.3% |
| Q4 2016 | $217,993,000 | +31.7% | 24,800,136 | +1.2% | 0.03% | +31.8% |
| Q3 2016 | $165,465,000 | +253.1% | 24,513,384 | +86.2% | 0.02% | +266.7% |
| Q2 2016 | $46,861,000 | +18.4% | 13,163,191 | -1.9% | 0.01% | +20.0% |
| Q1 2016 | $39,564,000 | -49.8% | 13,411,691 | -28.2% | 0.01% | -54.5% |
| Q4 2015 | $78,830,000 | -7.4% | 18,680,097 | +0.1% | 0.01% | -8.3% |
| Q3 2015 | $85,105,000 | -36.2% | 18,663,391 | +0.9% | 0.01% | -29.4% |
| Q2 2015 | $133,359,000 | -2.4% | 18,496,391 | -0.2% | 0.02% | 0.0% |
| Q1 2015 | $136,651,000 | +157.4% | 18,541,491 | +65.2% | 0.02% | +142.9% |
| Q4 2014 | $53,099,000 | +29.9% | 11,225,970 | -2.0% | 0.01% | +16.7% |
| Q3 2014 | $40,885,000 | -21.7% | 11,452,470 | +0.0% | 0.01% | -14.3% |
| Q2 2014 | $52,208,000 | -10.9% | 11,449,070 | -8.2% | 0.01% | -12.5% |
| Q1 2014 | $58,602,000 | -8.3% | 12,468,470 | -2.2% | 0.01% | -11.1% |
| Q4 2013 | $63,877,000 | +115.3% | 12,749,970 | +167.4% | 0.01% | +80.0% |
| Q3 2013 | $29,662,000 | +37.0% | 4,768,770 | 0.0% | 0.01% | +25.0% |
| Q2 2013 | $21,650,000 | – | 4,768,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |